White House COVID-19 chief: Vaccines will be ‘commercialized’ by 2023
The U.S. will pivot toward the “commercialization” of COVID-19 vaccines, treatments and tests in the coming year instead of a scenario in which the government is the main purchaser, according to the White House virus coordinator.
The Washington Times stories: White House